SIMON FARRELL enters TREVI THERAPEUTICS, INC. with 20.65K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/16/2023ACC: 0001209191-23-010184
Officer· Chief Commercial Officer
Since Feb 2026
20.65K
Baseline shares
100% direct
20.65K
Direct ownership
1 position
167.50K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned20.65K
Total
20.65K direct20.65K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.65K | Direct |
| Total | 20.65K | 20.65K direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
75K
Shares owned
N/A
Exercise price
3.91
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
75K
Shares owned
N/A
Exercise price
0.511
Expiration
—
Exercise window
—
Performance Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
17.50K
Shares owned
N/A
Exercise price
3.21
Expiration
—
Exercise window
—
Total
Underlying
167.50K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 3.91 | — | — | 75K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 0.511 | — | — | 75K | N/A |
| Performance Stock Option (right to buy) Direct | Common Stock | 3.21 | — | — | 17.50K | N/A |
| Total | 167.50K | 0.00 | ||||